A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) - Contacts and Locations

Home Search Study Topics Glossary

A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

This study has been completed.

Study NCT00047645. Last updated on November 1, 2007.

Information provided by InterMune

Please refer to this study by its ClinicalTrials.gov identifier: NCT00047645

Locations

United States, Washington
University of Washington Medical Center
Seattle, Washington, United States, 98195

Sponsors and Collaborators

InterMune

Investigators

Study Director:

Javier Szwarcberg, MD

InterMune